Marc P Bonaca Selected Research

Peripheral Arterial Disease

9/2022	Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
1/2022	Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease.
1/2022	Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
1/2022	Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
1/2022	Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
1/2022	Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
1/2022	Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease.
1/2022	Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial.
1/2022	Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
12/2021	Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc P Bonaca Research Topics

Disease

89	Myocardial Infarction 01/2022 - 02/2007
51	Peripheral Arterial Disease 09/2022 - 09/2009
43	Hemorrhage 09/2022 - 09/2009
42	Stroke (Strokes) 09/2022 - 04/2012
28	Acute Coronary Syndrome 01/2022 - 09/2008
26	Ischemic Stroke 01/2022 - 09/2009
22	Ischemia 01/2022 - 09/2008
18	Thrombosis (Thrombus) 01/2022 - 09/2008
16	Atherosclerosis 01/2022 - 09/2009
14	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
13	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 09/2008
12	Heart Failure 01/2021 - 01/2011
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2007
9	Hypertension (High Blood Pressure) 01/2022 - 01/2011
9	Diabetes Mellitus 01/2022 - 01/2011
6	Atrial Fibrillation 09/2022 - 12/2019
6	Transient Ischemic Attack 01/2022 - 12/2014
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 04/2012
6	Vascular Diseases (Vascular Disease) 11/2018 - 04/2013
5	Inflammation (Inflammations) 01/2022 - 09/2008
5	Coronary Disease (Coronary Heart Disease) 12/2021 - 06/2016
5	Chronic Renal Insufficiency 12/2021 - 06/2014
4	Weight Loss (Weight Reduction) 01/2019 - 01/2018
4	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 02/2007
3	Venous Thromboembolism 01/2022 - 01/2018
3	Anemia 12/2021 - 01/2021
3	Overweight 01/2019 - 01/2018
3	Chest Pain (Chest Pains) 04/2014 - 09/2013
2	COVID-19 01/2022 - 01/2021
2	Intermittent Claudication 01/2022 - 10/2017
2	Infections 01/2022 - 01/2019
2	Chronic Limb-Threatening Ischemia 11/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 01/2020 - 07/2016
2	Kidney Diseases (Kidney Disease) 01/2020 - 01/2019
2	Body Weight (Weight, Body) 10/2019 - 10/2019
2	Neoplasms (Cancer) 01/2019 - 12/2018
2	Hemorrhagic Stroke 09/2016 - 12/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 12/2014
1	Embolism (Embolus) 09/2022
1	Obesity 01/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Unstable Angina 01/2022

Drug/Important Bio-Agent (IBA)

30	TicagrelorIBA 01/2022 - 11/2013
27	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 10/2012
26	vorapaxarIBA 01/2022 - 09/2009
18	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2016
13	RivaroxabanIBA 01/2022 - 01/2018
10	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
7	Troponin IIBA 01/2021 - 07/2012
7	dapagliflozinIBA 01/2020 - 01/2018
6	Clopidogrel (Plavix)FDA Link 12/2021 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2008
6	Neurofibromin 2 (Merlin)IBA 10/2015 - 11/2011
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 05/2014
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021 - 09/2009
5	Sodium-Glucose Transport ProteinsIBA 01/2020 - 01/2019
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
4	AnticoagulantsIBA 01/2022 - 01/2021
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 02/2007
4	LDL CholesterolIBA 01/2021 - 01/2018
4	TroponinIBA 11/2020 - 09/2008
4	Thrombin FDA Link 10/2019 - 09/2009
4	Ranolazine FDA Link 06/2014 - 01/2012
3	evolocumabIBA 12/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 01/2011
3	saxagliptin FDA Link 01/2021 - 01/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2018
3	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2009
3	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
3	lorcaserinIBA 01/2019 - 01/2018
3	Peptide Hydrolases (Proteases)FDA Link 03/2017 - 04/2013
3	thienopyridineIBA 11/2015 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2012
2	LipidsIBA 10/2021 - 01/2021
2	darapladibIBA 01/2021 - 09/2014
2	oxidized low density lipoproteinIBA 01/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2020 - 01/2011
2	SodiumIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2018
2	Growth Differentiation Factor 15IBA 01/2019 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
2	Purinergic P2Y Receptor AntagonistsIBA 05/2015 - 04/2014
1	Warfarin (Coumadin)FDA LinkGeneric 09/2022
1	edoxabanIBA 09/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Liraglutide FDA Link 01/2022
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	semaglutideIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022

Therapy/Procedure

43	Therapeutics 01/2022 - 06/2009
28	Secondary Prevention 01/2022 - 09/2009
20	Surgical Amputation (Amputations) 01/2022 - 01/2018
11	Stents 01/2021 - 01/2012
6	Percutaneous Coronary Intervention 01/2022 - 02/2007
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2018 - 03/2009
2	Exercise Therapy (Therapy, Exercise) 02/2021 - 01/2021
2	Immunotherapy 01/2019 - 12/2018
1	Vascular Surgical Procedures 01/2022